RSEJX
Price
$67.20
Change
+$3.27 (+5.11%)
Updated
Feb 3 closing price
Net Assets
391.09M
VEXRX
Price
$111.06
Change
-$1.83 (-1.62%)
Updated
Feb 3 closing price
Net Assets
20.23B
Interact to see
Advertisement

RSEJX vs VEXRX

Header iconRSEJX vs VEXRX Comparison
Open Charts RSEJX vs VEXRXBanner chart's image
Victory RS Small Cap Growth R6
Price$67.20
Change+$3.27 (+5.11%)
VolumeN/A
Net Assets391.09M
Vanguard Explorer Adm
Price$111.06
Change-$1.83 (-1.62%)
VolumeN/A
Net Assets20.23B
RSEJX vs VEXRX Comparison Chart in %
View a ticker or compare two or three
VS
RSEJX vs. VEXRX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSEJX is a Hold and VEXRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.2B vs. RSEJX (391M). VEXRX pays higher dividends than RSEJX: VEXRX (0.54) vs RSEJX (0.00). RSEJX was incepted earlier than VEXRX: RSEJX (9 years) vs VEXRX (24 years). RSEJX (1.09) is less costly to investors than VEXRX (0.33). RSEJX is a more actively managed with annual turnover of: 120.00 vs. VEXRX (51.00). RSEJX has a lower initial minimum investment than VEXRX: RSEJX (0) vs VEXRX (50000). RSEJX annual gain was more profitable for investors over the last year : 5.31 vs. VEXRX (0.66). VEXRX return over 5 years is better than : -12.97 vs. RSEJX (-39.78).
RSEJXVEXRXRSEJX / VEXRX
Total Expense Ratio1.060.33321%
Annual Report Gross Expense Ratio1.090.33330%
Fund Existence9 years24 years-
Gain YTD4.2994.096105%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets391M20.2B2%
Annual Yield % from dividends0.000.54-
Returns for 1 year5.310.66803%
Returns for 3 years27.8813.57205%
Returns for 5 years-39.78-12.97307%
Returns for 10 yearsN/A72.29-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCYVX14.730.49
+3.44%
NYLI Candriam Emerging Markets Eq Inv Cl
GAAHX25.300.62
+2.51%
GMO Resources R6
FSMEX58.63N/A
N/A
Fidelity Select Medical Tech and Devcs
FBGKX269.83N/A
N/A
Fidelity Blue Chip Growth K
FGILX25.63N/A
N/A
Fidelity Global Equity Income